These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1402895

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J, Binns HJ.
    Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852
    [Abstract] [Full Text] [Related]

  • 4. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
    Raghavan S, Krusell A, Lyerla TA, Bremer EG, Kolodny EH.
    Biochim Biophys Acta; 1985 Apr 25; 834(2):238-48. PubMed ID: 3995063
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma GM2 ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-Gangliosidosis.
    Blondel A, Kraoua I, Marcelino C, Khrouf W, Schlemmer D, Ganne B, Caillaud C, Fernández-Eulate G, Turki IBY, Dauriat B, Bonnefont-Rousselot D, Nadjar Y, Lamari F.
    Mol Genet Metab; 2023 Feb 25; 138(2):106983. PubMed ID: 36709536
    [Abstract] [Full Text] [Related]

  • 8. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
    Kodama T, Togawa T, Tsukimura T, Kawashima I, Matsuoka K, Kitakaze K, Tsuji D, Itoh K, Ishida Y, Suzuki M, Suzuki T, Sakuraba H.
    PLoS One; 2011 Feb 25; 6(12):e29074. PubMed ID: 22205997
    [Abstract] [Full Text] [Related]

  • 9. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G, Harden A.
    Neuropediatrics; 1984 Sep 25; 15 Suppl():74-84. PubMed ID: 6100798
    [Abstract] [Full Text] [Related]

  • 10. Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses.
    Utz JR, Crutcher T, Schneider J, Sorgen P, Whitley CB.
    Mol Genet Metab; 2015 Feb 25; 114(2):274-80. PubMed ID: 25557439
    [Abstract] [Full Text] [Related]

  • 11. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.
    Neuenhofer S, Conzelmann E, Schwarzmann G, Egge H, Sandhoff K.
    Biol Chem Hoppe Seyler; 1986 Mar 25; 367(3):241-4. PubMed ID: 3707714
    [Abstract] [Full Text] [Related]

  • 12. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
    Akhunov VS, Mirenburg TV, Krasnopolskaya XD.
    J Inherit Metab Dis; 1994 Mar 25; 17(1):104-11. PubMed ID: 8051915
    [Abstract] [Full Text] [Related]

  • 13. Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis).
    Suzuki K, Chen GC.
    J Lipid Res; 1967 Mar 25; 8(2):105-13. PubMed ID: 14564716
    [Abstract] [Full Text] [Related]

  • 14. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
    Tsuji D.
    Yakugaku Zasshi; 2013 Mar 25; 133(2):269-74. PubMed ID: 23370522
    [Abstract] [Full Text] [Related]

  • 15. Glycosphingolipid degradation and animal models of GM2-gangliosidoses.
    Kolter T, Sandhoff K.
    J Inherit Metab Dis; 1998 Aug 25; 21(5):548-63. PubMed ID: 9728335
    [Abstract] [Full Text] [Related]

  • 16. Characterization of neutral and acidic glycosphingolipids in brains of two patients with GM1 gangliosidosis type 1 and type 2.
    Ishikawa Y, Makita A, Minami R.
    J Neurochem; 1985 Apr 25; 44(4):1100-6. PubMed ID: 3919156
    [Abstract] [Full Text] [Related]

  • 17. Ganglioside accumulation in cultured skin fibroblasts from gangliosidosis patients.
    Pullarkat RK, Reha H, Beratis NG.
    Biochem Biophys Res Commun; 1980 Jan 15; 92(1):149-54. PubMed ID: 7356448
    [No Abstract] [Full Text] [Related]

  • 18. A possible biomarker of neurocytolysis in infantile gangliosidoses: aspartate transaminase.
    Kılıç M, Kasapkara ÇS, Kılavuz S, Mungan NÖ, Biberoğlu G.
    Metab Brain Dis; 2019 Apr 15; 34(2):495-503. PubMed ID: 30712135
    [Abstract] [Full Text] [Related]

  • 19. Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
    Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, d'Azzo A, Perry VH, Butters TD, Dwek RA, Platt FM.
    Brain; 2003 Apr 15; 126(Pt 4):974-87. PubMed ID: 12615653
    [Abstract] [Full Text] [Related]

  • 20. Western blotting analysis of the beta-hexosaminidase alpha- and beta-subunits in cultured fibroblasts from cases of various forms of GM2 gangliosidosis.
    Utsumi K, Tsuji A, Kase R, Tanaka A, Tanaka T, Uyama E, Ozawa T, Sakuraba H, Komaba Y, Kawabe M, Iino Y, Katayama Y.
    Acta Neurol Scand; 2002 Jun 15; 105(6):427-30. PubMed ID: 12027830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.